{"brief_title": "A Study of an Investigational Medication for Severe Primary Hyperparathyroidism or Parathyroid Cancer", "brief_summary": "This study will assess an investigational medication for patients with severe primary hyperparathyroidism or parathyroid cancer.", "condition": "Parathyroid Neoplasms", "intervention_type": "Drug", "intervention_name": "AMG 073", "criteria": "- Patients must have parathyroid carcinoma or severe primary hyperparathyroidism; * Abnormally elevated calcium levels above 12.5 mg/dL; * Not be pregnant or nursing; * Not have had any type of cancer other than parathyroid carcinoma within the last 5 years.", "gender": "All", "minimum_age": "18 Years", "maximum_age": "N/A", "healthy_volunteers": "No", "id": "NCT00037518.xml"}